Brain Tumor Treatments: Arizona

Sponsored By

Cedars-Siani Medical Center Brain Tumor Program

Please Click On The Above Banner For More Details

[Click HERE to print this page!]

Search Term: Arizona
Please scroll down to see the matching trials.

  (0.8351) Advanced Search
  (0.8351) Brain Tumor Treatments: Arizona
  (0.7967) Brain Tumor Centers
  (0.7967) Noteworthy Treatments For Brain Tumors
  (0.7967) Brain Tumor Support Groups
  (0.7967) Brain Tumor Support Groups
  (0.7967) IFN-Beta Gene Transfer
  (0.7967) RSR-13
  (0.7967) RSR-13
  (0.7967) RSR-13
  (0.7742) Untitled Document
  (0.7742) Brain Tumor Centers
  (0.7742) Brain Tumor Centers
  (0.7742) Chemosensitivity Testing
  (0.7742) Brain Tumor Activism
  (0.7742) Letter Writing Wizard
  (0.7742) Brain Tumor Activism
  (0.7742) Virtualtrials Newsletter

Sorry - There were no pages found that contain that search phrase.


	Treatment	Location	Last Updated

Details	Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme	Phoenix, AZ USA	04/11/2008

Details	NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303	Phoenix, AZ USA	03/01/2008

Details	A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas	Phoenix, AZ USA	05/01/2007

Details	Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer	Phoenix, AZ USA	05/01/2007

Details	Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas	Phoenix, AZ USA	04/29/2007

Details	Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas	Phoenix, AZ USA	04/29/2007

Details	Phase I/II Study of Sorafenib and Temsirolimus in Patients With Recurrent Glioblastoma	Scottsdale/Phoenix, AZ USA	04/28/2007

Details	Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study)	Phoenix, AZ USA	10/12/2006

Details	Phase I Study of Temsirolimus and Concurrent Chemoradiotherapy Comprising Temozolomide and Radiotherapy Followed By Adjuvant Temsirolimus and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme	Scottsdale/Phoenix, AZ USA	08/11/2006

Details	Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors	Scottsdale/Phoenix, AZ USA	06/26/2006

Details	Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme	Scottsdale/Phoenix, AZ USA	06/26/2006

Details	Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma	Phoenix, AZ USA	05/30/2006

Details	Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme	Phoenix, AZ USA	05/29/2006

Details	Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma	Phoenix, AZ USA	11/27/2005

Details	A Multicenter Phase II Study of TP-38 in Those Patients With Glioblastoma Multiforme Who Have Recurred or Progressed After Previous Resection and Radiation Therapy and Are Scheduled for Gross Total Resection	Phoenix, AZ USA	11/13/2005

Details	Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors	Scottsdale, AZ USA	11/06/2005

Details	A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy	Phoenix, AZ USA	11/06/2005